SARS-CoV-2 and lung injury: Dysregulation of immune response but not hyperimmune response as in "cytokine storm syndrome"
CLINICAL RESPIRATORY JOURNAL, vol.16, no.1, pp.13-16, 2022 (SCI-Expanded, Scopus)
- Publication Type: Article / Review
- Volume: 16 Issue: 1
- Publication Date: 2022
- Doi Number: 10.1111/crj.13455
- Journal Name: CLINICAL RESPIRATORY JOURNAL
- Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, EMBASE, MEDLINE
- Page Numbers: pp.13-16
- Keywords: ALI, ARDS, critically ill patients, dysregulation of immune response, SARS-CoV-2, T-CELLS
- Hacettepe University Affiliated: Yes
Abstract
SARS-CoV-2 infection can present either an asymptomatic or symptomatic; the spectrum of symptomatic infection ranges from mild to critical. A majority of patients have experienced mild symptoms with a good prognosis. But approximately 14% of them have severe infection presenting with hypoxemia and extensive lung involvement. The current mini-review describes the dysregulation of immune response for SARS-CoV-2 viral pneumonia and virus-induced lung injury. Also, many confounding factors can increase lung injury, in addition to virus-induced lung injury. Especially in critically ill patients, confounding factors can cause the inflammatory cascade, acute respiratory distress syndrome (ARDS), and mortality.